Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 5 (2008), Issue 1 (January)

1. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease.
   FASEB J, 22(1): 138-45. [Abstract] [Full-text]
2. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
   Eur J Neurol, 15(1): 61-5. [Abstract] [Full-text]
3. Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration.
   Eur J Neurol, 15(1): 77-81. [Abstract] [Full-text]
4. Losing one's memory in early Alzheimer's disease.
   Qual Health Res, 18(1): 31-42. [Abstract] [Full-text]
5. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
   Ann Pharmacother, 42(1): 32-8. [Abstract] [Full-text]
6. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine.
   Neurobiol Aging, 29(2): 168-84. [Abstract] [Full-text]
7. Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.
   Neurobiol Aging, 29(2): 185-93. [Abstract] [Full-text]
8. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease.
   Neurobiol Aging, 29(2): 194-202. [Abstract] [Full-text]
9. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
   Neurobiol Aging, 29(2): 241-52. [Abstract] [Full-text]
10. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Neurobiol Aging, 29(2): 210-21. [Abstract] [Full-text]
11. Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography.
    Neurobiol Aging, 29(2): 203-9. [Abstract] [Full-text]
12. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
    Biochem Biophys Res Commun, 366(3): 631-6. [Abstract] [Full-text]
13. Transitioning residents from nursing facilities to community living: who wants to leave?
    J Am Geriatr Soc, 56(1): 1-7. [Abstract] [Full-text]
14. Caries prevalence in older persons with and without dementia.
    J Am Geriatr Soc, 56(1): 59-67. [Abstract] [Full-text]
15. Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study.
    J Am Geriatr Soc, 56(1): 37-44. [Abstract] [Full-text]
16. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population.
    J Am Geriatr Soc, 56(1): 51-8. [Abstract] [Full-text]
17. Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project.
    J Am Geriatr Soc, 56(1): 111-6. [Abstract] [Full-text]
18. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
    Genes Brain Behav, 7: 57-66. [Abstract] [Full-text]
19. Neurotrophic factors in Alzheimer's disease: role of axonal transport.
    Genes Brain Behav, 7: 43-56. [Abstract] [Full-text]
20. Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models.
    Genes Brain Behav, 7: 1-5. [Abstract] [Full-text]
21. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion.
    J Biol Chem, 283(3): 1744-53. [Abstract] [Full-text]
22. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Neurology, 70(3): 191-9. [Abstract] [Full-text]
23. Variable phenotype of Alzheimer's disease with spastic paraparesis.
    J Neurochem, 104(3): 573-83. [Abstract] [Full-text]
24. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    J Neurochem, 104(3): 846-58. [Abstract] [Full-text]
25. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 79(2): 176-9. [Abstract] [Full-text]
26. Variant Creutzfeldt-Jacob disease: the second case in Portugal and in the same geographical region.
    J Neurol Neurosurg Psychiatry, 79(2): 180-2. [Abstract] [Full-text]
27. Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry, 79(2): 126-9. [Abstract] [Full-text]
28. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    J Neurol Neurosurg Psychiatry, 79(2): 130-5. [Abstract] [Full-text]
29. Prolonged activation EEG differentiates dementia with and without delirium in frail elderly patients.
    J Neurol Neurosurg Psychiatry, 79(2): 119-25. [Abstract] [Full-text]
30. The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro.
    Arch Biochem Biophys, 470(1): 83-92. [Abstract] [Full-text]
31. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Neurology, 70(4): 299-303. [Abstract] [Full-text]
32. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
    J Neuroinflammation, 5: 2. [Abstract] [Full-text]
33. Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease.
    Acta Radiol, 49(1): 91-7. [Abstract] [Full-text]
34. Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry.
    Acta Radiol, 49(1): 84-90. [Abstract] [Full-text]
35. Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics?
    Eur J Neurol, 15(2): 199-201. [Abstract] [Full-text]
36. Codon 129 polymorphism of prion protein gene in sporadic Alzheimer's disease.
    Eur J Neurol, 15(2): 173-8. [Abstract] [Full-text]
37. Sodium lactate differently alters relative EEG power and functional connectivity in Alzheimer's disease patients' brain regions.
    Eur J Neurol, 15(2): 150-5. [Abstract] [Full-text]
38. The tau S305S mutation causes frontotemporal dementia with parkinsonism.
    Eur J Neurol, 15(2): 156-61. [Abstract] [Full-text]
39. The impact of neurological illness on marital relationships.
    J Sex Marital Ther, 34(2): 115-32. [Abstract] [Full-text]
40. Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
    Stroke, 39(2): 317-22. [Abstract] [Full-text]
41. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
    Neurology, 70(5): 368-73. [Abstract] [Full-text]
42. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
    Am J Med Genet C Semin Med Genet, 148(1): 47-55. [Abstract] [Full-text]
43. Membrane fusogenic activity of the Alzheimer's peptide A beta(1-42) demonstrated by small-angle neutron scattering.
    J Mol Biol, 376(2): 393-404. [Abstract] [Full-text]
44. An update on huperzine A as a treatment for Alzheimer's disease.
    Expert Opin Investig Drugs, 17(2): 209-15. [Abstract] [Full-text]
45. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
    J Neurosci, 28(5): 1213-23. [Abstract] [Full-text]
46. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.
    J Neurochem, 104(4): 1065-80. [Abstract] [Full-text]
47. Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools.
    J Neurochem, 104(4): 859-74. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.